Taurus Asset Management LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,054 shares of the biopharmaceutical company’s stock after selling 73 shares during the quarter. Regeneron Pharmaceuticals accounts […]
TrinityPoint Wealth LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 262 shares of the biopharmaceutical company’s stock after acquiring an additional 12 shares during the quarter. TrinityPoint Wealth […]
3Chopt Investment Partners LLC bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 599 shares of the biopharmaceutical company’s stock, valued at approximately $526,000. Several other institutional investors and hedge funds have also recently modified their […]
Commerce Bank raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,217 shares of the biopharmaceutical company’s stock after acquiring an additional 257 shares during the period. Commerce Bank’s holdings in […]
Balentine LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,399 shares of the biopharmaceutical company’s stock after purchasing an additional 97 shares during the period. Balentine LLC’s […]